3 Biotech Stocks Surge with Momentum

Rockwell Medical, Cardiol Therapeutics, and Sonoma Pharmaceuticals see stock price gains amid healthcare innovation

Apr. 10, 2026 at 12:21pm

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, polished gears and machinery in shades of steel gray, bronze, and chrome, conceptually representing the complex financial and technological infrastructure powering the biotech industry.Biotech stocks surge as investors seek innovative healthcare solutions amid industry evolution.Sonoma Today

As the global healthcare landscape evolves, biotech companies focused on targeted therapies and innovative treatment solutions are gaining prominence among investors. Several emerging companies, including Rockwell Medical Inc. (RMTI), Cardiol Therapeutics Inc. (CRDL), and Sonoma Pharmaceuticals Inc. (SNOA), have recently seen strong stock price momentum, drawing attention for their strategic positioning and recent market activity.

Why it matters

The growing emphasis on precision medicine and disease-specific interventions is shaping the biotech industry and influencing stock performance. Investors are closely watching these companies as they execute on clinical programs, advance pipeline assets, and position themselves for long-term success in the evolving healthcare landscape.

The details

Rockwell Medical Inc. (RMTI) saw its stock price dip slightly on April 9, 2026, closing at $0.94, but the company's Earnings Per Share (EPS) is up 50% this year. Cardiol Therapeutics Inc. (CRDL) closed at $1.38, up 6.98%, with trading volume exceeding its average and a market cap of $154.119 million. Sonoma Pharmaceuticals Inc. (SNOA) opened strong on April 9, jumping 5.24% to $2.41 before closing at $2.29.

  • On April 9, 2026, Rockwell Medical Inc. (RMTI) stock closed at $0.94.
  • On April 9, 2026, Cardiol Therapeutics Inc. (CRDL) stock closed at $1.38, up 6.98%.
  • On April 9, 2026, Sonoma Pharmaceuticals Inc. (SNOA) stock opened at $2.41, up 5.24%, before closing at $2.29.

The players

Rockwell Medical Inc.

A publicly-traded healthcare company focused on targeted therapies and innovative treatment solutions.

Cardiol Therapeutics Inc.

A publicly-traded biopharmaceutical company developing innovative therapies for the treatment of cardiovascular disease.

Sonoma Pharmaceuticals Inc.

A publicly-traded healthcare company focused on the development and commercialization of pharmaceutical products for the treatment of various medical conditions.

Got photos? Submit your photos here. ›

The takeaway

The strong performance of these biotech stocks highlights the growing investor interest in companies developing innovative healthcare solutions. As the industry continues to evolve, these companies' ability to execute on their strategic priorities and deliver meaningful clinical outcomes will be key to unlocking long-term shareholder value.